{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T16:59:21Z","timestamp":1776704361549,"version":"3.51.2"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Regional Key Research and Development Program of Ningxia","award":["2022BEG02055"],"award-info":[{"award-number":["2022BEG02055"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14972-6","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:29:55Z","timestamp":1760012995000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Immediate risk and 5-year cumulative risk of high-grade cervical lesions in high-risk HPV-positive patients with minor cytological abnormalities: a retrospective single-center study in China"],"prefix":"10.1186","volume":"25","author":[{"given":"Linghua","family":"Kong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoping","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ru","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuanzheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3700-637X","authenticated-orcid":false,"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"key":"14972_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 10","key":"14972_CR2","doi-asserted-by":"publisher","first-page":"K1","DOI":"10.1016\/j.vaccine.2008.05.064","volume":"26","author":"FX Bosch","year":"2008","unstructured":"Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S, Bruni L, et al. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine. 2008;26(Suppl 10):K1\u201316.","journal-title":"Vaccine"},{"key":"14972_CR3","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1001\/jama.2023.13174","volume":"330","author":"RB Perkins","year":"2023","unstructured":"Perkins RB, Wentzensen N, Guido RS, Schiffman M. Cervical cancer screening: a review. JAMA. 2023;330:547\u201358.","journal-title":"JAMA"},{"key":"14972_CR4","unstructured":"World Health Organization. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention[M]. 2nd edition. Geneva: World Health Organization. 2021:1\u201345."},{"key":"14972_CR5","doi-asserted-by":"publisher","first-page":"313","DOI":"10.23736\/S0026-4784.19.04397-1","volume":"71","author":"SA Pimple","year":"2019","unstructured":"Pimple SA, Mishra GA. Global strategies for cervical cancer prevention and screening. Minerva Ginecol. 2019;71:313\u201320.","journal-title":"Minerva Ginecol"},{"key":"14972_CR6","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1001\/jama.2019.4595","volume":"321","author":"GF Sawaya","year":"2019","unstructured":"Sawaya GF, Smith-McCune K, Kuppermann M. Cervical cancer screening: more choices in 2019. JAMA. 2019;321:2018\u20139.","journal-title":"JAMA"},{"key":"14972_CR7","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","volume":"24","author":"RB Perkins","year":"2020","unstructured":"Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, et al. 2019 ASCCP Risk-Based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. J Lower Genit Tract Dis. 2020;24:102\u201331.","journal-title":"J Lower Genit Tract Dis"},{"key":"14972_CR8","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/S0002-9378(03)00418-6","volume":"188","author":"Atypical Squamous Cells of Undetermined Significance-LowGrade Squamous Intraepithelial Lesion Triage Study (ALTS) Group","year":"2003","unstructured":"Atypical Squamous Cells of Undetermined Significance-LowGrade Squamous Intraepithelial Lesion Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol. 2003;188:1383\u201392.","journal-title":"Am J Obstet Gynecol"},{"key":"14972_CR9","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.5858\/2004-128-1224-BIARRP","volume":"128","author":"DD Davey","year":"2004","unstructured":"Davey DD, Neal MH, Wilbur DC, Colgan TJ, Styer PE, Mody DR. Bethesda 2001 implementation and reporting rates: 2003 practices of participants in the college of American pathologists interlaboratory comparison program in cervicovaginal cytology. Arch Pathol Lab Med. 2004;128:1224\u20139.","journal-title":"Arch Pathol Lab Med"},{"key":"14972_CR10","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1097\/LGT.0b013e3182854253","volume":"17","author":"HA Katki","year":"2013","unstructured":"Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, et al. Five-year risks of CIN 3\u2009+\u2009and cervical cancer among women with HPV testing of ASC-US pap results. J Lower Genit Tract Dis. 2013;17:S36\u201342.","journal-title":"J Lower Genit Tract Dis"},{"key":"14972_CR11","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.5858\/arpa.2018-0603-CP","volume":"143","author":"DD Davey","year":"2019","unstructured":"Davey DD, Souers RJ, Goodrich K, Mody DR, Tabbara SO, Booth CN. Bethesda 2014 implementation and human papillomavirus primary screening: practices of laboratories participating in the college of American pathologists PAP education program. Arch Pathol Lab Med. 2019;143:1196\u2013202.","journal-title":"Arch Pathol Lab Med"},{"key":"14972_CR12","first-page":"81","volume":"34","author":"M Pajtler","year":"2010","unstructured":"Pajtler M, Milici\u0107-Juhas V, Milojkovi\u0107 M, Topolovec Z, Curzik D, Mihaljevi\u0107 I. Assessment of HPV DNA test value in management women with cytological findings of ASC-US, CIN1 and CIN2. Coll Antropol. 2010;34:81\u20136.","journal-title":"Coll Antropol"},{"key":"14972_CR13","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/cncy.21521","volume":"123","author":"R Nayar","year":"2015","unstructured":"Nayar R, Wilbur DC. The pap test and Bethesda 2014. Cancer Cytopathol. 2015;123:271\u201381.","journal-title":"Cancer Cytopathol"},{"key":"14972_CR14","unstructured":"Board WcoTE. WHO classification of tumours.Female genital tumours [M]. 5th edtion. Lyon: IARC Press. 2020: 342\u2013346. 2020."},{"key":"14972_CR15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/GCO.0000000000000241","volume":"28","author":"S Pimple","year":"2016","unstructured":"Pimple S, Mishra G, Shastri S. Global strategies for cervical cancer prevention. Curr Opin Obstet Gynecol. 2016;28:4\u201310.","journal-title":"Curr Opin Obstet Gynecol"},{"key":"14972_CR16","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.hoc.2024.03.005","volume":"38","author":"VV Sahasrabuddhe","year":"2024","unstructured":"Sahasrabuddhe VV. Cervical cancer: precursors and prevention. Hematol Oncol Clin North Am. 2024;38:771\u201381.","journal-title":"Hematol Oncol Clin North Am"},{"key":"14972_CR17","doi-asserted-by":"publisher","first-page":"429","DOI":"10.5483\/BMBRep.2022.55.9.042","volume":"55","author":"JE Lee","year":"2022","unstructured":"Lee JE, Chung Y, Rhee S, Kim TH. Untold story of human cervical cancers: HPV-negative cervical cancer. BMB Rep. 2022;55:429\u201338.","journal-title":"BMB Rep"},{"key":"14972_CR18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/cac2.12629","volume":"45","author":"M Xu","year":"2025","unstructured":"Xu M, Cao C, Wu P, Huang X, Ma D. Advances in cervical cancer: current insights and future directions. Cancer Commun (London England). 2025;45:77\u2013109.","journal-title":"Cancer Commun (London England)"},{"key":"14972_CR19","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1159\/000441290","volume":"59","author":"CQ Lin","year":"2015","unstructured":"Lin CQ, Cui JF, Zhang X, Pan QJ, Chen W, Qiao YL. Human papillomavirus genotyping to predict the risk of cervical precancerous lesions or cancer in women with minor abnormal cytology in China. Acta Cytol. 2015;59:405\u201311.","journal-title":"Acta Cytol"},{"key":"14972_CR20","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.jiph.2023.02.014","volume":"16","author":"AAA Oyouni","year":"2023","unstructured":"Oyouni AAA. Human papillomavirus in cancer: infection, disease transmission, and progress in vaccines. J Infect Public Health. 2023;16:626\u201331.","journal-title":"J Infect Public Health"},{"key":"14972_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1159\/000320877","volume":"55","author":"A Heider","year":"2011","unstructured":"Heider A, Austin RM, Zhao C. HPV test results stratify risk for histopathologic follow-up findings of high-grade cervical intra-epithelial neoplasia in women with low-grade squamous intra-epithelial lesion pap results. Acta Cytol. 2011;55:48\u201353.","journal-title":"Acta Cytol"},{"key":"14972_CR22","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/cncy.20172","volume":"119","author":"AW Levi","year":"2011","unstructured":"Levi AW, Harigopal M, Hui P, Schofield K, Chhieng DC. Use of high-risk human papillomavirus testing in patients with low-grade squamous intraepithelial lesions. Cancer Cytopathol. 2011;119:228\u201334.","journal-title":"Cancer Cytopathol"},{"key":"14972_CR23","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/dc.21209","volume":"38","author":"MJ Thrall","year":"2010","unstructured":"Thrall MJ, Smith DA, Mody DR. Women >or = 30 years of age with low grade squamous intraepithelial lesion (LSIL) have low positivity rates when cotested for high-risk human papillomavirus: should we reconsider HPV triage for LSIL in older women? Diagn Cytopathol. 2010;38:407\u201312.","journal-title":"Diagn Cytopathol"},{"key":"14972_CR24","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.ygyno.2019.05.012","volume":"154","author":"TC Jr. Wright","year":"2019","unstructured":"Wright TC Jr., Stoler MH, Parvu V, Yanson K, Cooper C, Andrews J. Risk detection for high-grade cervical disease using onclarity HPV extended genotyping in women, \u2265 21 years of age, with ASC-US or LSIL cytology. Gynecol Oncol. 2019;154:360\u20137.","journal-title":"Gynecol Oncol"},{"key":"14972_CR25","doi-asserted-by":"publisher","first-page":"331","DOI":"10.5858\/134.3.331","volume":"134","author":"GM Eversole","year":"2010","unstructured":"Eversole GM, Moriarty AT, Schwartz MR, Clayton AC, Souers R, Fatheree LA, et al. Practices of participants in the college of American pathologists interlaboratory comparison program in cervicovaginal cytology, 2006. Arch Pathol Lab Med. 2010;134:331\u20135.","journal-title":"Arch Pathol Lab Med"},{"key":"14972_CR26","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/dc.25150","volume":"51","author":"H Xu","year":"2023","unstructured":"Xu H, Chen Y, Zhao C, Wang Q, Tang M, Zhang W, et al. Bethesda system reporting rates, histological follow-up and HPV genotypes distribution of abnormal cytology in Anhui Province of china: analysis of 93,168 cervical liquid-based cytology test reports. Diagn Cytopathol. 2023;51:501\u201310.","journal-title":"Diagn Cytopathol"},{"key":"14972_CR27","doi-asserted-by":"publisher","first-page":"118","DOI":"10.7326\/M15-2735","volume":"166","author":"M Arbyn","year":"2017","unstructured":"Arbyn M, Xu L, Verdoodt F, Cuzick J, Szarewski A, Belinson JL, et al. Genotyping for human papillomavirus types 16 and 18 in women with minor cervical lesions: a systematic review and meta-analysis. Ann Intern Med. 2017;166:118\u201327.","journal-title":"Ann Intern Med"},{"key":"14972_CR28","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.ygyno.2017.11.025","volume":"148","author":"WD Kang","year":"2018","unstructured":"Kang WD, Ju UC, Kim SM. Is human papillomavirus genotype important in predicting disease progression in women with biopsy-proven negative or CIN1 of atypical squamous cell of undetermined significance (ASC-US). cytology? Gynecol Oncol. 2018;148:305\u201310.","journal-title":"Gynecol Oncol"},{"key":"14972_CR29","first-page":"1528","volume":"06","author":"ZX JIA Rongxia","year":"2022","unstructured":"JIA Rongxia ZX, Zhikun SHI, Meijing BAO, Guanqun WANG, Yuqing CHU, Yang LIN. Analysis on risk factors for disease progression of patients with cervical intraepithelial neoplasia \u2160. J Jilin Univ (Medicine Edition). 2022;06:1528\u201334. (In Chinease with English abstract).","journal-title":"J Jilin Univ (Medicine Edition)"},{"key":"14972_CR30","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1159\/000497286","volume":"84","author":"J Zhang","year":"2019","unstructured":"Zhang J, Lu CX. Spontaneous regression of cervical intraepithelial neoplasia 2: a meta-analysis. Gynecol Obstet Invest. 2019;84:562\u20137.","journal-title":"Gynecol Obstet Invest"},{"key":"14972_CR31","first-page":"516","volume":"58","author":"MX Wu","year":"2023","unstructured":"Wu MX, He XM, You ZX. [Analysis of natural regression and influencing factors of HSIL in the cervix of childbearing age patients]. Zhonghua Fu Chan Ke Za Zhi. 2023;58:516\u201325.","journal-title":"Zhonghua Fu Chan Ke Za Zhi"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14972-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14972-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14972-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:29:57Z","timestamp":1760012997000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14972-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14972"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14972-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"assertion":[{"value":"8 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1541"}}